Ready To Schedule A Free Consultation?

Solutions to Protect and Grow Your Business


Five Rivers RX offers the comprehensive capabilities and the deep industry knowledge necessary to help you solve your organization’s most complex issues. Based right outside of Philadelphia, we’ve been operating since 2015, and each year, we have a bigger list of clients who keep coming back because they know we’re the best at what we do.

Leadership


Sumeet Singh

President

ssingh@fiveriversrx.com

Sumeet started his career at a regional drug wholesaler as the head of special projects including state licensing and software ERP implementation. He moved on to take a leadership role at a regional, full-line pharmaceutical distributor with responsibilities spanning purchasing, sales, operations, and finance. With the 2015 implementation of the DSCSA, Sumeet gained expertise in all aspects of the federal law as he led the creation and implementation of new processes and systems. Sumeet founded his first start-up in 2015: OpenRX, a described “Amazon” for pharmaceuticals. He sold this company to an operating private equity firm just 12 months after inception.

In late 2015, Sumeet founded Five Rivers RX. Drawing on the relationships and knowledge he cultivated at the helm of a distribution company, Sumeet is able to bring a unique “boots on the ground” understanding of the industry. With over 300 clients spanning Fortune 500 companies to venture-backed start-ups and independent companies, Five Rivers RX has established itself as a go-to resource for 16 different business models in the pharmaceutical supply chain.

Sumeet Singh has been published in trade publications including Pharmaceutical Commerce and has spoken at events including American Conference Institute Controlled Substances Summit, IQPC Pharmaceutical Traceability Forum, and Chain76.

Advisory Board


Vinu Pillai

Vinu is an experienced healthcare attorney with a significant background in the pharmaceutical & healthcare provision sectors. He has advanced expertise in the areas of the anti-kickback statute, corporate compliance, Federal & State regulatory matters, fraud & abuse, government affairs, group purchasing organizations, healthcare M&A, 340b issues, pharmaceutical distribution, and privacy/HIPAA.

Benjamin Maizel

Benjamin has extensive experience in strategic commercialization, sales, marketing, and distribution aspects of the pharmaceutical industry. He is a knowledgeable, self-reliant, hands-on executive with experience from start-ups to restructuring, as well as with launching companies into the United States market. His developed experiential skillset extends from international manufacturing to sales, marketing, and consulting, to cross-functional team leadership.